Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yasemin Aydınalp Camadan
Observed names:
Y. Aydinalp Camadan,
Yasemin AYDINALP CAMADAN,
Yasemin Aydinalp Camadan,
Yasemin Aydınalp
Institutions:
Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Seyhan Devlet Hastanesi,
Cukurova University
Observed institutions:
Adana Hospital,
Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Seyhan Devlet Hastanesi,
Cukurova University
ORCID:
0000-0003-2435-368X
Observed ORCID:
0000-0003-2435-368X
OpenAlex ID:
A5098727609
HALP Score in Predicting Response to Treatment in Patients with Early-Stage Gastric Cancer: A Multi-Centred Retrospective Cohort Study
2024
·
Tolga Köşeci
, Mustafa Seyyar
, et al.
·
Medicina
·
15
PDF
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
2023
·
Çağlar Ünal
, Abdulmunir Azizy
, et al.
·
The Oncologist
·
11
PDF
Can the Pathological Response in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant Treatment Be Predicted by the CEA/Albumin and CRP/Albumin Ratios?
2024
·
Ertugrul Bayram
, Mehmet Mutlu Kidi
, et al.
·
Journal of Clinical Medicine
·
8
The Correlation Between PD-L1 Expression in Metaplastic Breast Cancer and Clinical-Pathological Features and Prognosis
2026
·
Tugba Toyran
, Ertuğrul Bayram
, et al.
·
Medicina
·
2
PDF
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer
2026
·
Ali Aytac
, Bilgin Demir
, et al.
·
Medicina
·
1
PDF
Current developments in small cell lung cancer
2024
·
Yasemin Aydınalp Camadan
·
Scientific reports in medicine.
·
1
PDF
Pre-Treatment CD44 and CD47 Expression and Pathological Complete Response After Neoadjuvant Therapy in Breast Cancer: An Exploratory Single-Center Study
2026
·
Hatice Asoglu
, Esra Asarkaya
, et al.
·
International Journal of Molecular Sciences
EZH2 expression in diffuse large B-cell lymphoma: clinicopathological associations and relationship with survival
2026
·
Mehmet Mutlu Kıdı
, Mehmet Türker
, et al.
·
Çukurova medical journal (Online)/Çukurova medical journal
PDF
Prognostic Value of Pretreatment Modified Glasgow Prognostic Score in Nivolumab-Treated Advanced Non-Small Cell Lung Cancer
2026
·
Sedat Biter
, Mehmet Mutlu Kıdı
, et al.
·
Journal of Clinical Medicine
Clinicopathological Features, Treatment Modalities, and Prognostic Factors of Leptomeningeal Carcinomatosis in Patients with Breast Cancer: A Single-Center Retrospective Analysis
2026
·
Mehmet Mutlu Kıdı
, Ömer Kaya
, et al.
·
Cukurova Anestezi ve Cerrahi Bilimler Dergisi
PDF
Is There a Tumor Proportion Score Threshold at Which Tumor-Cell PD-L1 Adds Prognostic Information Beyond the International Prognostic Index in Large B-Cell Lymphoma?
2026
·
Mehmet Mutlu Kidi
, Suheda Atas Ipek
, et al.
·
Diagnostics
Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy: A Multicentre Retrospective Cohort Study
2026
·
Sedat Biter
, Ertuğrul Bayram
, et al.
·
Medicina
EZH2 Expression and Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Retrospective Cohort Study
2026
·
Esra Asarkaya
, Hatice Asoglu
, et al.
·
Journal of Clinical Medicine
Quantitative Immunohistochemical Landscapes and Chemoimmunotherapy Outcomes of ASCL1, NEUROD1, POU2F3, and YAP1 in Pure Small-Cell Lung Cancer: A Pilot Study
2026
·
Yasemin Aydinalp Camadan
, Arzu Demir Ispir
, et al.
·
Journal of Clinical Medicine
Clinicopathological Features, Tumor Localization and Treatment Outcomes in Paraganglioma: A Single-Center Medical Oncology Cohort
2026
·
Hatice Asoglu
, Esra Asarkaya
, et al.
·
Diagnostics
The predictive and prognostic value of the Advanced Lung Cancer Inflammation Index in metastatic NSCLC receiving second-line nivolumab: a multicenter retrospective cohort study
2026
·
Ali Aytaç
, Bilgin Demir
, et al.
·
Journal of Current Hematology & Oncology Research
Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group
2026
·
Mustafa Seyyar
, Pervin Can Şancı
, et al.
·
BMC Cancer
Malignancies After Kidney Transplantation
2026
·
Yasemin Aydınalp Camadan
, Tolga Köşeci
·
Akademisyen Kitabevi eBooks
Complications After Kidney Transplantation
2026
·
Ayşegül Yetişir
, Mehmet Taylan Peköz
, et al.
·
Akademisyen Kitabevi eBooks
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study
2026
·
Suheda Atas Ipek
, Sendag Yaslikaya
, et al.
·
Journal of Clinical Medicine
PDF
Clinical and demographic characteristics in ameloblastoma patients: A single-center study.
2026
·
Yasemin Aydinalp Camadan
, Ertugrul Bayram
, et al.
·
Journal of Clinical Oncology
PDF
Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid Tumors
2026
·
Sendag Yaslikaya
, Suheda Atas Ipek
, et al.
·
Journal of Clinical Medicine
Refractory thrombocytopenia after 177Lu-PSMA therapy: bone marrow infiltration (myelophthisis) versus treatment toxicity
2026
·
Yasemin Aydinalp Camadan
, Ertugrul Bayram
, et al.
·
Scientific reports in medicine.
118P Can CD 47 be a targeted treatment in desmoid tumors?
2025
·
S. Yaslikaya
, E. Asarkaya
, et al.
·
ESMO Open
PDF
Single-center Experience in Diffuse Large B-cell Lymphoma: Prognostic Value of Demographic and Molecular Characteristics
2024
·
Şehmus Tan
, Mehmet Mutlu Kıdı
, et al.
·
Hematology Transfusion and Cell Therapy
Show more works
View as search
Works count:
30
Citation count:
38
H-index:
3
I10-index:
2
Year
Topic
Type